HEADER UNKNOWN FUNCTION 18-DEC-03 1RXH TITLE CRYSTAL STRUCTURE OF STREPTAVIDIN MUTANT L124R (M1) COMPLEXED WITH TITLE 2 BIOTINYL P-NITROANILIDE (BNI) COMPND MOL_ID: 1; COMPND 2 MOLECULE: STREPTAVIDIN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOMYCES AVIDINII; SOURCE 3 ORGANISM_TAXID: 1895; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PET-21A KEYWDS AVIDIN, STREPTAVIDIN, PSEUDO ENZYMATIC ACTIVITY, UNKNOWN FUNCTION EXPDTA X-RAY DIFFRACTION AUTHOR Y.EISENBERG-DOMOVICH,Y.PAZY,O.NIR,B.RABOY,E.A.BAYER,M.WILCHEK, AUTHOR 2 O.LIVNAH REVDAT 5 14-FEB-24 1RXH 1 REMARK REVDAT 4 27-OCT-21 1RXH 1 REMARK SEQADV REVDAT 3 13-JUL-11 1RXH 1 VERSN REVDAT 2 24-FEB-09 1RXH 1 VERSN REVDAT 1 11-MAY-04 1RXH 0 JRNL AUTH Y.EISENBERG-DOMOVICH,Y.PAZY,O.NIR,B.RABOY,E.A.BAYER, JRNL AUTH 2 M.WILCHEK,O.LIVNAH JRNL TITL STRUCTURAL ELEMENTS RESPONSIBLE FOR CONVERSION OF JRNL TITL 2 STREPTAVIDIN TO A PSEUDOENZYME JRNL REF PROC.NATL.ACAD.SCI.USA V. 101 5916 2004 JRNL REFN ISSN 0027-8424 JRNL PMID 15079055 JRNL DOI 10.1073/PNAS.0308541101 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 5309 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.309 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 294 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1789 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 50 REMARK 3 SOLVENT ATOMS : 16 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1RXH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-DEC-03. REMARK 100 THE DEPOSITION ID IS D_1000021117. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-OCT-02 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MAX FLUX REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 5466 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.05 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 7555 Y,X,-Z+2/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+1/3 REMARK 290 10555 -Y,-X,-Z+1/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 159.04733 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 79.52367 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 119.28550 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 39.76183 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 198.80917 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 159.04733 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 79.52367 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 39.76183 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 119.28550 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 198.80917 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: TWO MONOMERS IN THE ASYMMETRIC UNIT STARTING AT RESIDUES 13 REMARK 300 AND 213. THE SECOND PART OF THE BIOLOGICAL ASSEMBLY IS GENERATED BY REMARK 300 THE SYMMETRY OPERATION -Y,-X,-Z+1/6 REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 11200 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18910 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -33.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.500000 -0.866025 0.000000 56.38500 REMARK 350 BIOMT2 2 -0.866025 -0.500000 0.000000 97.66168 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 39.76183 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 13 REMARK 465 GLU A 14 REMARK 465 VAL A 133 REMARK 465 LYS A 134 REMARK 465 PRO A 135 REMARK 465 SER A 136 REMARK 465 ALA A 137 REMARK 465 ALA A 138 REMARK 465 SER A 139 REMARK 465 ALA B 213 REMARK 465 GLU B 214 REMARK 465 SER B 336 REMARK 465 ALA B 337 REMARK 465 ALA B 338 REMARK 465 SER B 339 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 49 64.90 -102.49 REMARK 500 SER A 52 -169.96 66.23 REMARK 500 ASP A 67 -107.40 -59.88 REMARK 500 SER A 69 157.21 -47.98 REMARK 500 LEU A 73 -165.31 -167.38 REMARK 500 TRP A 79 59.66 -67.93 REMARK 500 ASN A 81 -152.99 -151.14 REMARK 500 SER A 88 143.33 178.96 REMARK 500 GLU A 116 -32.99 -35.48 REMARK 500 LYS A 121 31.63 -93.12 REMARK 500 GLU B 251 118.97 -177.69 REMARK 500 SER B 252 -173.69 81.10 REMARK 500 ALA B 263 74.79 -118.94 REMARK 500 ASP B 267 -134.72 -67.42 REMARK 500 SER B 269 131.44 -6.00 REMARK 500 ASN B 281 -148.58 -158.61 REMARK 500 HIS B 287 70.89 44.86 REMARK 500 ALA B 300 -71.87 -63.68 REMARK 500 LYS B 334 141.93 132.99 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BNI A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BNI B 502 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1IJ8 RELATED DB: PDB REMARK 900 RELATED ID: 1I9H RELATED DB: PDB REMARK 900 RELATED ID: 1RXJ RELATED DB: PDB REMARK 900 RELATED ID: 1RXK RELATED DB: PDB DBREF 1RXH A 13 139 UNP P22629 SAV_STRAV 37 163 DBREF 1RXH B 213 339 UNP P22629 SAV_STRAV 37 163 SEQADV 1RXH ARG A 124 UNP P22629 LEU 148 ENGINEERED MUTATION SEQADV 1RXH ARG B 324 UNP P22629 LEU 148 ENGINEERED MUTATION SEQRES 1 A 127 ALA GLU ALA GLY ILE THR GLY THR TRP TYR ASN GLN LEU SEQRES 2 A 127 GLY SER THR PHE ILE VAL THR ALA GLY ALA ASP GLY ALA SEQRES 3 A 127 LEU THR GLY THR TYR GLU SER ALA VAL GLY ASN ALA GLU SEQRES 4 A 127 SER ARG TYR VAL LEU THR GLY ARG TYR ASP SER ALA PRO SEQRES 5 A 127 ALA THR ASP GLY SER GLY THR ALA LEU GLY TRP THR VAL SEQRES 6 A 127 ALA TRP LYS ASN ASN TYR ARG ASN ALA HIS SER ALA THR SEQRES 7 A 127 THR TRP SER GLY GLN TYR VAL GLY GLY ALA GLU ALA ARG SEQRES 8 A 127 ILE ASN THR GLN TRP LEU LEU THR SER GLY THR THR GLU SEQRES 9 A 127 ALA ASN ALA TRP LYS SER THR ARG VAL GLY HIS ASP THR SEQRES 10 A 127 PHE THR LYS VAL LYS PRO SER ALA ALA SER SEQRES 1 B 127 ALA GLU ALA GLY ILE THR GLY THR TRP TYR ASN GLN LEU SEQRES 2 B 127 GLY SER THR PHE ILE VAL THR ALA GLY ALA ASP GLY ALA SEQRES 3 B 127 LEU THR GLY THR TYR GLU SER ALA VAL GLY ASN ALA GLU SEQRES 4 B 127 SER ARG TYR VAL LEU THR GLY ARG TYR ASP SER ALA PRO SEQRES 5 B 127 ALA THR ASP GLY SER GLY THR ALA LEU GLY TRP THR VAL SEQRES 6 B 127 ALA TRP LYS ASN ASN TYR ARG ASN ALA HIS SER ALA THR SEQRES 7 B 127 THR TRP SER GLY GLN TYR VAL GLY GLY ALA GLU ALA ARG SEQRES 8 B 127 ILE ASN THR GLN TRP LEU LEU THR SER GLY THR THR GLU SEQRES 9 B 127 ALA ASN ALA TRP LYS SER THR ARG VAL GLY HIS ASP THR SEQRES 10 B 127 PHE THR LYS VAL LYS PRO SER ALA ALA SER HET BNI A 501 25 HET BNI B 502 25 HETNAM BNI 5-(2-OXO-HEXAHYDRO-THIENO[3,4-D]IMIDAZOL-6-YL)- HETNAM 2 BNI PENTANOIC ACID (4-NITRO-PHENYL)-AMIDE HETSYN BNI BIOTINYL P-NITROANILINE FORMUL 3 BNI 2(C16 H20 N4 O4 S) FORMUL 5 HOH *16(H2 O) HELIX 1 1 ASN A 118 LYS A 121 5 4 HELIX 2 2 THR B 315 TRP B 320 1 6 SHEET 1 A10 THR A 123 GLY A 126 0 SHEET 2 A10 ARG A 103 SER A 112 -1 N LEU A 110 O ARG A 124 SHEET 3 A10 THR A 129 THR A 131 -1 O PHE A 130 N ILE A 104 SHEET 4 A10 GLY A 19 TYR A 22 -1 N TYR A 22 O THR A 131 SHEET 5 A10 THR A 28 ALA A 33 -1 O PHE A 29 N TRP A 21 SHEET 6 A10 ALA A 38 GLU A 44 -1 O THR A 40 N THR A 32 SHEET 7 A10 ARG A 53 TYR A 60 -1 O GLY A 58 N LEU A 39 SHEET 8 A10 THR A 71 LYS A 80 -1 O GLY A 74 N ARG A 59 SHEET 9 A10 ASN A 85 VAL A 97 -1 O THR A 90 N VAL A 77 SHEET 10 A10 ARG A 103 SER A 112 -1 O GLN A 107 N SER A 93 SHEET 1 B10 TYR B 254 VAL B 255 0 SHEET 2 B10 ALA B 238 GLU B 244 -1 N TYR B 243 O TYR B 254 SHEET 3 B10 THR B 257 TYR B 260 -1 O GLY B 258 N LEU B 239 SHEET 4 B10 THR B 271 LYS B 280 -1 O GLY B 274 N ARG B 259 SHEET 5 B10 ASN B 285 VAL B 297 -1 O TYR B 296 N THR B 271 SHEET 6 B10 ARG B 303 SER B 312 -1 O ARG B 303 N VAL B 297 SHEET 7 B10 THR B 323 THR B 331 -1 O ARG B 324 N LEU B 310 SHEET 8 B10 GLY B 219 ASN B 223 -1 N TYR B 222 O THR B 331 SHEET 9 B10 THR B 228 ALA B 233 -1 O PHE B 229 N TRP B 221 SHEET 10 B10 ALA B 238 GLU B 244 -1 O GLU B 244 N THR B 228 SITE 1 AC1 17 ASN A 23 LEU A 25 SER A 27 TYR A 43 SITE 2 AC1 17 SER A 45 VAL A 47 GLY A 48 ASN A 49 SITE 3 AC1 17 TRP A 79 ALA A 86 SER A 88 THR A 90 SITE 4 AC1 17 TRP A 108 LEU A 110 ARG A 124 ASP A 128 SITE 5 AC1 17 TRP B 320 SITE 1 AC2 16 ASN B 223 LEU B 225 SER B 227 TYR B 243 SITE 2 AC2 16 SER B 245 VAL B 247 ASN B 249 THR B 266 SITE 3 AC2 16 ASP B 267 TRP B 279 ALA B 286 SER B 288 SITE 4 AC2 16 THR B 290 TRP B 308 ARG B 324 ASP B 328 CRYST1 56.385 56.385 238.571 90.00 90.00 120.00 P 65 2 2 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017735 0.010239 0.000000 0.00000 SCALE2 0.000000 0.020479 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004192 0.00000